Translational science. Strategic innovation.

From biological insight to meaningful impact.

StratG Innovations supports discovery and translational research through integrated biological services, patient-derived models, biobanking, advanced analytics and next-generation AI.

Discovery Services Patient-Derived Models Next Gen AI
About StratG

Science connected across the discovery journey.

We bring together experimental biology, tissue-based research, patient-derived systems and data-led approaches to help research teams generate decision-ready evidence. Our model is collaborative, flexible and designed around the scientific question.

Integrated Biology

Assays and models aligned to project milestones.

Actionable Data

Clear outputs for confident next-step decisions.

Innovate to Impact

Our focus is not simply to run experiments, but to build research strategies that connect robust laboratory execution with translational relevance.

Understand
Define the scientific question and decision criteria.
Design
Select models, assays and readouts with purpose.
Deliver
Generate interpretable evidence and clear reporting.


Our Vision

"Empowering health, Enriching Lives, serving humanity by pioneering innovations in Bio-Medical Research for the greater need"

Our Team

Leadership across science, pathology and research.

Meet the leadership team driving StratG Innovations' translational science, pathology and research programs.

BiologyCell and biochemical platforms
PathologyTissue and image intelligence
DataAI-enabled interpretation
StrategyTranslational study design
Dr. M.S.N. Prasad

Dr. M.S.N. Prasad

Chairman & Managing Director
Click to view profile
Mr. Roshan Shetty

Mr. Roshan Shetty P

Director, Chief Scientific Officer
Click to view profile
Mr. Amar

Mr. Amar

Research Director
Click to view profile



Biobank

Access to well-annotated biospecimens can strengthen target validation, biomarker research and model development. StratG's biobank capability is structured to support ethical sourcing, sample traceability, quality documentation and fit-for-purpose research use.

Tissue specimensBlood derivativesClinical annotationTraceable workflows

Sample Access

Research-grade biospecimens selected according to study-specific inclusion criteria and availability.

Quality & Traceability

Documented handling, storage and sample-level metadata to support reproducible research.

Linked Workflows

Biobank samples can connect directly with histopathology, IHC, cell isolation and model generation.

Custom Studies

Study design support for tissue-based biomarker assessment and translational research questions.

Services

A connected platform for preclinical discovery.

Modular services can be commissioned independently or integrated into a larger program.

Discovery Services

In vitro Cell-based Assays

Functional and phenotypic assays designed to evaluate compound activity, pathway modulation, viability, proliferation and mechanism-related endpoints.

Biochemical Assays

Target-focused assay development and execution using quantitative readouts for activity, inhibition, binding and pathway-relevant biochemistry.

DMPK

In vitro drug metabolism and pharmacokinetic support to characterize stability, permeability, protein binding and related developability parameters.

Histopathology / IHC

Tissue processing, staining, morphology assessment and immunohistochemistry workflows for biomarker localization and response evaluation.

Immunocytochemistry

Cell-based protein localization and expression analysis using optimized staining, imaging and quantitative interpretation workflows.

Custom Assay Development

Fit-for-purpose assay design, optimization and validation tailored to target biology, sample type and development stage.

3D Cell Culture Model

Biology with greater physiological relevance.

Three-dimensional models help bridge the gap between conventional monolayer assays and complex in vivo biology.



Spheroid Assays

Formation, growth, treatment response and image-based analysis of multicellular spheroids.



Organoid Assays

Patient-relevant organoid culture and compound testing for translational and precision-research applications.

Patient-Derived Cell (PDC) Platform

Primary Cell Isolation

Isolation and establishment of primary cells from appropriate patient-derived specimens using optimized handling workflows.

Characterization

Morphological, phenotypic and molecular characterization to document model identity and key biological features.

Patient-Derived 3D Models

Development of spheroid and organoid systems to enable response profiling in a more representative cellular context.

Next Gen AI

Turn complex biological images and data into insight.

AI-assisted workflows can support image quantification, feature extraction, response classification and integrated data interpretation while maintaining scientist-led review.

Explore an AI Collaboration

Digital Pathology

Image analysis for tissue morphology, staining patterns and biomarker quantification.


Predictive Models

Pattern recognition and decision-support approaches for complex research datasets.

Drug Repurposing

Find new therapeutic possibilities in known molecules.

Our drug-repurposing approach combines biological rationale, evidence review, model selection and experimental validation to identify and prioritize new opportunities for existing or previously investigated compounds.

Opportunity mapping
Connect disease biology, targets and existing compound evidence.
Prioritization
Rank candidates using translational relevance and testability.
Experimental validation
Evaluate shortlisted molecules in fit-for-purpose assays and models.

A strategy-led pathway

Reduce exploratory uncertainty by aligning computational hypotheses with relevant experimental evidence.

Start a Conversation
Contact Us

Let us build the right research path together.

Tell us about your target, model, assay or translational challenge. Our team will connect with you to discuss a tailored approach.

Project enquiry